Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 150

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 300

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 450
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks

Summary

In recent years technological innovation has revolutionized almost all markets and industries. This combined with growing political uncertainty, slumps in consumer demand and shifting growth rates in developing economies has thrust many industries and markets into a brave new world.

Key Highlights

The North American pharmaceuticals market has performed poorly in recent years, due primarily to poor economic growth and moderate government austerity during the Obama administration.

In the future, market growth is expected to accelerate.

Johnson & Johnson leads the North American market, generating approximately $70bn in revenues in 2016.

Scope

Details market value and revenue growth rates, both historically and forecast.

Identifies the largest and most important companies in the market.

Compares the growth, in revenue and net profits, of each company over time.

Reviews how successfully each company utilizes its employees.

Considers share prices and their relative fluctuation over time.

Provides a breakdown of each company's performance, reviewing revenue, profit, share prices and the most recent quarterly performance.

Reasons to buy

What is the value of the market?

How has the value of the market changed historically?

How is the market forecast to perform in the future?

What are the leading companies in the market?

How does the performance of the leading companies compare?

How have their revenues and profits changed over time?

How does the share price growth of the leading companies compare?

How volatile are the share prices of the leading companies?

How has each leading company performed on a quarterly basis?

READ MORE

Table Of Content

Scope

Table of Contents

Introduction

Pharmaceuticals Market Segmentation: Market Value

Pharmaceuticals Market Segmentation: Value Growth

Top 10 Pharmaceuticals companies: Revenue

Top 10 Pharmaceuticals companies: Revenue Growth

Top 10 Pharmaceuticals companies: Revenue & Net Profit

Top 10 Pharmaceuticals companies: Profit

Top 10 Pharmaceuticals companies: Net Profit Margin

Top 10 Pharmaceuticals companies: Revenue Per Employee

Top 10 Pharmaceuticals companies: Share Price

Top 10 Pharmaceuticals companies: Revenue vs. Debt

Top 10 Pharmaceuticals companies: Companies

Appendix

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Gilead Sciences

Johnson & Johnson

Pfizer

Roche

Novartis

Amgen

Merck & Co.

Sanofi

AbbVie

AstraZeneca

Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks

Summary

In recent years technological innovation has revolutionized almost all markets and industries. This combined with growing political uncertainty, slumps in consumer demand and shifting growth rates in developing economies has thrust many industries and markets into a brave new world.

Key Highlights

The North American pharmaceuticals market has performed poorly in recent years, due primarily to poor economic growth and moderate government austerity during the Obama administration.

In the future, market growth is expected to accelerate.

Johnson & Johnson leads the North American market, generating approximately $70bn in revenues in 2016.

Scope

Details market value and revenue growth rates, both historically and forecast.

Identifies the largest and most important companies in the market.

Compares the growth, in revenue and net profits, of each company over time.

Reviews how successfully each company utilizes its employees.

Considers share prices and their relative fluctuation over time.

Provides a breakdown of each company's performance, reviewing revenue, profit, share prices and the most recent quarterly performance.

Reasons to buy

What is the value of the market?

How has the value of the market changed historically?

How is the market forecast to perform in the future?

What are the leading companies in the market?

How does the performance of the leading companies compare?

How have their revenues and profits changed over time?

How does the share price growth of the leading companies compare?

How volatile are the share prices of the leading companies?

How has each leading company performed on a quarterly basis?

READ MORE

Scope

Table of Contents

Introduction

Pharmaceuticals Market Segmentation: Market Value

Pharmaceuticals Market Segmentation: Value Growth

Top 10 Pharmaceuticals companies: Revenue

Top 10 Pharmaceuticals companies: Revenue Growth

Top 10 Pharmaceuticals companies: Revenue & Net Profit

Top 10 Pharmaceuticals companies: Profit

Top 10 Pharmaceuticals companies: Net Profit Margin

Top 10 Pharmaceuticals companies: Revenue Per Employee

Top 10 Pharmaceuticals companies: Share Price

Top 10 Pharmaceuticals companies: Revenue vs. Debt

Top 10 Pharmaceuticals companies: Companies

Appendix

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Gilead Sciences

Johnson & Johnson

Pfizer

Roche

Novartis

Amgen

Merck & Co.

Sanofi

AbbVie

AstraZeneca